TLR9 and cancer: Nevertheless, when the data are considered in its entirety, that is, across all three groups (i.e., patients with cancer and EBV(+), patients with cancer and EBV(−), and the Control Group), it becomes evident that patients with PCa and a positive EBV status exhibit the highest levels of both TLR-2 and TLR-9.